Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China flag China · Delayed Price · Currency is CNY
15.96
-0.13 (-0.81%)
Apr 30, 2026, 3:00 PM CST

SHA:603079 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
571.11457.67315.62323.72320.72514.75
Short-Term Investments
--30-1020.07
Trading Asset Securities
32.02182.060.013.01-0.01
Cash & Short-Term Investments
603.14639.73345.63326.74330.72534.83
Cash Growth
118.87%85.09%5.78%-1.20%-38.16%-6.40%
Accounts Receivable
140.86159.06141.24119.26135.9133.38
Other Receivables
0.420.370.550.60.850.17
Receivables
141.28159.43141.79119.86136.75133.55
Inventory
219.87189.74197.54228.48292.06222.09
Other Current Assets
22.1221.523.8120.0720.8328.35
Total Current Assets
986.411,010708.77695.15780.36918.81
Property, Plant & Equipment
919.71894.67769.47674.77561.81579.96
Long-Term Investments
10.710.721.0160.760.720.74
Goodwill
10.9110.9110.9110.9110.9110.91
Other Intangible Assets
221.25222.94225.58231.82218.2156.09
Long-Term Deferred Tax Assets
6.767.010.060.895.363.38
Long-Term Deferred Charges
1.121.956.168.674.236.87
Other Long-Term Assets
35.6539.9643.3536.2813.6468.06
Total Assets
2,1932,1991,7851,7191,6551,765
Accounts Payable
169.59182.18155.44129.61164151.33
Accrued Expenses
13.6627.8838.3133.8437.5736.03
Short-Term Debt
--30.8294.7541.76167.39
Current Portion of Long-Term Debt
4.046.320.110.14--
Current Portion of Leases
--0.80.30.590.59
Current Income Taxes Payable
8.0416.173.382.985.043.21
Current Unearned Revenue
5.994.493.82.928.76.54
Other Current Liabilities
9.159.6618.7130.937.8147.4
Total Current Liabilities
210.47246.7251.38295.45295.46412.5
Long-Term Debt
330.71317.75231144--
Long-Term Leases
--0.49-0.30.87
Long-Term Unearned Revenue
8.276.786.655.467.586.95
Long-Term Deferred Tax Liabilities
4.434.433.714.288.437.53
Other Long-Term Liabilities
8.18.18.1---
Total Liabilities
561.97583.75501.34449.2311.78427.84
Common Stock
189.03189.03171.19171.19171.19171.19
Additional Paid-In Capital
912.17911.96669.19669.19669.19669.19
Retained Earnings
517.86504.68442.53423.26487.6480.09
Treasury Stock
-21.13-21.13-22.08-8.97--
Comprehensive Income & Other
0.22-----
Total Common Equity
1,5981,5851,2611,2551,3281,320
Minority Interest
32.3930.2523.1415.3115.4516.49
Shareholders' Equity
1,6311,6151,2841,2701,3431,337
Total Liabilities & Equity
2,1932,1991,7851,7191,6551,765
Total Debt
334.75324.07263.23239.242.65168.85
Net Cash (Debt)
268.38315.6782.487.54288.07365.98
Net Cash Growth
-283.08%-5.86%-69.61%-21.29%-18.70%
Net Cash Per Share
1.471.780.480.521.652.13
Filing Date Shares Outstanding
188.21176.97169.32169.32171.19171.19
Total Common Shares Outstanding
188.21176.97169.32170.46171.19171.19
Working Capital
775.94763.71457.38399.69484.9506.32
Book Value Per Share
8.498.957.457.367.767.71
Tangible Book Value
1,3661,3511,0241,0121,0991,153
Tangible Book Value Per Share
7.267.636.055.946.426.74
Buildings
--290.21279.73274.11272.42
Machinery
--589.14528.41515.04479.2
Construction In Progress
--335.96247.3293.3388.76
Source: S&P Global Market Intelligence. Standard template. Financial Sources.